Annual Congress: Hematologic Malignancies

2020-hem-web-header

NCCN 2021 Virtual Congress: Hematologic Malignancies™
Live Virtual Program was held Thursday, October 14, 2021 – Saturday, October 16, 2021

Save the Date! The NCCN 2022 Annual Congress: Hematologic Malignancies™ will take place Friday, October 14, 2022 – Saturday, October 15, 2022, in New York, New York.

Continuing Education

Congress attendees will have the opportunity to view conference sessions on-demand in the Digitell platform through December 17, 2021.

Recorded sessions will be available in the NCCN Continuing Education Portal, education.nccn.org, in December.

Co-chairs Ranjana H. Advani, MD, Stanford Cancer Institute, and Andrew D. Zelenetz, MD, PhD, Memorial Sloan Kettering Cancer Center, led expert discussions on the latest advances, updates to the NCCN Guidelines®, and unique and challenging patient cases.


Accreditation

This program is approved for AMA PRA Category 1 Credit™ for physicians and will award contact hours for nurses, pharmacists, and other health care professionals.


Related Programs

Recorded Presentations from the NCCN 2021 Virtual Nursing Forum: Advancing Oncology Nursing in Hematologic Malignancies™ are now available.

View Recorded Presentations


Virtual Exhibition Hall

Congress attendees can continue to access the NCCN Virtual Exhibition Hall and Patient Advocacy Pavilion in the Digitell platform through December 17, 2021.

    Exhibition Guide


    Supporters

    Supported by educational grants from AstraZeneca; Daiichi Sankyo; Gilead Sciences, Inc. and Kite, A Gilead Company; GlaxoSmithKline; Novartis; Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; Pfizer Inc.; Seagen Inc. (formerly Seattle Genetics, Inc.); and Takeda. This educational activity is supported by a medical education grant from Karyopharm® Therapeutics. This activity is supported by independent medical education grants from ADC Therapeutics, Pharmacyclics LLC and Janssen and Jazz Pharmaceuticals. This activity is supported by an independent educational grant from Merck & Co., Inc. This activity is supported by an independent medical education grant from Bristol Myers Squibb. Provided by an independent medical education grant from MorphoSys.


    Commercial Sponsors


    Gold Level Sponsors

    BeiGene
    Incyte
    Janssen Oncology


    Silver Level Sponsors

    AstraZeneca
    Oncopeptides
    Pharmacyclics, an AbbVie Company and Janssen Biotech, Inc.


    Bronze Level Sponsors

    AbbVie 
    Astellas
    Jazz Pharmaceuticals
    Karyopharm Therapeutics, Inc.
    Spectrum Pharmaceuticals, Inc


    NCCN Patient Advocacy Pavilion Sponsors


    Ruby

    Pharmacyclics LLC., an AbbVie Company


    Emerald

    AstraZeneca
    BeiGene, Ltd.
    Coherus BioSciences
    Eisai Inc.
    Genentech
    Incyte
    Invitae
    Janssen Oncology
    Karyopharm Therapeutics, Inc.
    Kite Oncology
    Oncopeptides
    Sanofi Genzyme


    Topaz

    AbbVie
    AmerisourceBergen
    GSK
    Heron
    Natera
    Novartis


    Jade

    Servier
    Takeda
    TG Therapeutics

     

     

    Save the dates!

    NCCN 2022 Annual Congress: Hematologic Malignancies™
    New York Marriott Marquis • New York, New York
    Friday, October 14, 2022 – Saturday, October 15, 2022

    NCCN 2023 Annual Congress: Hematologic Malignancies™
    Hilton San Francisco Union Square • San Francisco, California
    Friday, September 22, 2023 – Saturday, September 23, 2023